1. Home
  2. CRGX vs ODC Comparison

CRGX vs ODC Comparison

Compare CRGX & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • ODC
  • Stock Information
  • Founded
  • CRGX 2021
  • ODC 1941
  • Country
  • CRGX United States
  • ODC United States
  • Employees
  • CRGX N/A
  • ODC N/A
  • Industry
  • CRGX
  • ODC Miscellaneous manufacturing industries
  • Sector
  • CRGX
  • ODC Consumer Discretionary
  • Exchange
  • CRGX Nasdaq
  • ODC Nasdaq
  • Market Cap
  • CRGX 621.4M
  • ODC 310.1M
  • IPO Year
  • CRGX 2023
  • ODC N/A
  • Fundamental
  • Price
  • CRGX $13.46
  • ODC $42.74
  • Analyst Decision
  • CRGX Strong Buy
  • ODC
  • Analyst Count
  • CRGX 6
  • ODC 0
  • Target Price
  • CRGX $31.80
  • ODC N/A
  • AVG Volume (30 Days)
  • CRGX 231.3K
  • ODC 32.1K
  • Earning Date
  • CRGX 03-20-2025
  • ODC 03-06-2025
  • Dividend Yield
  • CRGX N/A
  • ODC 1.45%
  • EPS Growth
  • CRGX N/A
  • ODC 36.22
  • EPS
  • CRGX N/A
  • ODC 3.09
  • Revenue
  • CRGX N/A
  • ODC $454,094,000.00
  • Revenue This Year
  • CRGX N/A
  • ODC N/A
  • Revenue Next Year
  • CRGX N/A
  • ODC N/A
  • P/E Ratio
  • CRGX N/A
  • ODC $13.81
  • Revenue Growth
  • CRGX N/A
  • ODC 6.61
  • 52 Week Low
  • CRGX $10.91
  • ODC $29.48
  • 52 Week High
  • CRGX $33.92
  • ODC $46.50
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 47.00
  • ODC 54.49
  • Support Level
  • CRGX $12.51
  • ODC $41.51
  • Resistance Level
  • CRGX $15.75
  • ODC $43.79
  • Average True Range (ATR)
  • CRGX 1.09
  • ODC 1.28
  • MACD
  • CRGX 0.17
  • ODC -0.21
  • Stochastic Oscillator
  • CRGX 52.74
  • ODC 50.86

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

Share on Social Networks: